Skip to main content
Equibles

Dana Investment Advisors, Inc.

Position in AVXL — Anavex Life Sciences Corp.

CIK 1427514 BROOKFIELD, WI
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$52,851
-$9,795 QoQ
Shares Held
20,406
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 179 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. AVXL ranks #12 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 57,520 $18,181,496
2 AXSM
Axsome Therapeutics, Inc.
 22,850 $5,592,994
3 REGN
Regeneron Pharmaceuticals, Inc.
 7,719 $4,813,105
4 TGTX
Tg Therapeutics, Inc.
 42,012 $2,308,139
5 VKTX
Viking Therapeutics, Inc.
 57,854 $2,256,884
6 MDGL
Madrigal Pharmaceuticals, Inc.
 3,677 $1,974,365
7 ZYME
Zymeworks Inc.
 71,660 $1,873,192
8 IONS
Ionis Pharmaceuticals Inc
 23,272 $1,845,236

All Filings in AVXL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $52,851 20,406
2026-03-31 $62,646 20,406
2025-12-31 $72,645 20,406
2025-09-30 $181,613 20,406
2025-06-30 $109,303 11,855
2025-03-31 $101,715 11,855
2024-12-31 $127,322 11,855
2024-09-30 $67,336 11,855
2024-06-30 $50,028 11,855
2024-03-31 $60,341 11,855
2023-12-31 $110,370 11,855
2023-09-30 $77,650 11,855
2023-06-30 $96,381 11,855
2023-03-31 $91,570 10,685
2022-12-31 $98,943 10,685
2022-09-30 $110,269 10,685
2022-06-30 $106,956 10,685
2022-03-31 $131,532 10,685